Hercules Capital Announces Date for Release of Third Quarter 2023 Financial Results and Conference Call

$HCXY
$HTGC
Investment Managers
Finance
Get the next $HCXY alert in real time by email

Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2023 financial results conference call for Thursday, November 2, 2023, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day.

To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. While not required, it is recommended you join 10 minutes prior to the event start. A live webcast of the third quarter 2023 financial results conference call will also be available on the investor relations section of the Company's website at investor.htgc.com. An archived webcast replay will be available on the Company's website for at least 30 days following the conference call.

About Hercules Capital, Inc.

Hercules Capital, Inc. (NYSE:HTGC) is the leading and largest specialty finance company focused on providing senior secured venture growth loans to high-growth, innovative venture capital-backed companies in a broad variety of technology, life sciences and sustainable and renewable technology industries. Since inception (December 2003), Hercules has committed more than $17 billion to over 630 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. Companies interested in learning more about financing opportunities should contact info@htgc.com, or call 650.289.3060.

Hercules, through its wholly owned subsidiary business, Hercules Adviser LLC ("Hercules Adviser"), also maintains an asset management business through which it manages investments for external parties ("Adviser Funds"). Hercules Adviser is registered as an investment adviser under the Investment Advisers Act of 1940.

Hercules' common stock trades on the New York Stock Exchange (NYSE) under the ticker symbol "HTGC." In addition, Hercules has one retail bond issuance of 6.25% Notes due 2033 (NYSE:HCXY).

Get the next $HCXY alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$HCXY
$HTGC

CompanyDatePrice TargetRatingAnalyst
12/12/2024$19.50 → $21.50Mkt Perform → Outperform
Keefe Bruyette
1/16/2024$17.00 → $17.50Buy → Neutral
Compass Point
11/21/2023$17.00Neutral
UBS
8/30/2023$17.50Neutral → Buy
Compass Point
8/4/2023$13.50 → $17.00Underperform → Mkt Perform
Keefe Bruyette
4/6/2023$16.00Neutral → Overweight
Piper Sandler
3/13/2023$14.50 → $10.50Mkt Perform → Underperform
Keefe Bruyette
7/29/2022Outperform → Perform
Oppenheimer
More analyst ratings

$HCXY
$HTGC
Press Releases

Fastest customizable press release news feed in the world

See more
  • Remodel Health Raises More Than $100 Million to Continue Expansion in ICHRA Market

    INDIANAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Remodel Health, the #1 Individual Coverage Health Reimbursement Arrangement (ICHRA) provider for brokers, today announced it has raised more than $100 million from Oak HC/FT and Hercules Capital, Inc. (NYSE:HTGC)  in growth funding. Remodel Health has raised more than $100 million from Oak HC/FT and Hercules Capital, Inc. in growth funding.Remodel offers an end-to-end, white-labeled tech platform that supports employers and employees with everything they need to launch and access their ICHRA plans, including plan creation and adminis

    $HTGC
    Investment Managers
    Finance
  • Hercules Capital Renews and Increases Its Multi-Currency SMBC Credit Facility to $300.0 Million

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has renewed and upsized its existing $225.0 million credit facility with Sumitomo Mitsui Banking Corporation ("SMBC") with an upsized credit facility under which Synovus Bank, Customers Bank and Apple Bank, together with SMBC, have committed a total of $300.0 million in credit capacity subject to borrowing base, leverage and other restrictions. The renewed credit facility also includes an uncommitte

    $HCXY
    $HTGC
    Investment Managers
    Finance
  • Alector Secures Flexible Credit Facility for Up to $50 Million From Hercules Capital

    SOUTH SAN FRANCISCO, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (NASDAQ:ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that the Company has entered into a debt financing agreement with Hercules Capital, Inc. (NYSE:HTGC) for up to $50 million. "Alector is in a strong cash position with more than $457 million in cash and investments. This credit facility further enhances our financial strength and provides the Company with increased strategic and operational flexibility," said Marc Grasso, M.D., Chief Financial Officer of Alector. "We anticipate transformational data from both the AL002 INVOKE-2 Phase 2 trial and the latozinemab INFRO

    $ALEC
    $HTGC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Investment Managers
    Finance

$HCXY
$HTGC
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$HCXY
$HTGC
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$HCXY
$HTGC
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$HCXY
$HTGC
SEC Filings

See more

$HCXY
$HTGC
Leadership Updates

Live Leadership Updates

See more
  • Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer

    SAUSALITO, Calif., Nov. 29, 2023 /PRNewswire/ -- Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer. Mr. Olson has an extensive background in the venture capital and funds management industry. His addition to the team will enhance the firm's technical expertise, support the differentiated investment model, and strengthen the firm's ongoing foundation. As the firm's new Chief Financial Officer and Chief Operating Officer

    $HTGC
    $TPVG
    Investment Managers
    Finance
    Other Consumer Services
    Consumer Discretionary
  • Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Nikos Theodosopoulos was appointed to serve as an independent member of its board of directors, effective September 21, 2023. Mr. Theodosopoulos is an experienced corporate executive and board director with more than 38 years in senior management roles in both the financial services and technology industries. Mr. Theodosopoulos will serve on the Company's Audit Committee. "Nikos' combined experienc

    $HCXY
    $HTGC
    Investment Managers
    Finance
  • Hercules Capital Announces the Appointment of Ms. DeAnne Aguirre to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that DeAnne Aguirre was appointed to serve as an independent member of its board of directors, effective June 23, 2022. Ms. Aguirre is an experienced corporate executive and Board Director with more than 30 years in senior leadership managing large and complex domestic and international business units. Ms. Aguirre will serve on the Nominating and Corporate Governance Committee. "As we continue to expand o

    $HCXY
    $HTGC
    Investment Managers
    Finance

$HCXY
$HTGC
Financials

Live finance-specific insights

See more
  • Hercules Capital Reports Third Quarter 2024 Financial Results

    Record Q3 2024 Total Investment Income of $125.2 Million, an Increase of 7.3% Year-over-Year Q3 2024 Net Investment Income "NII" of $83.2 Million, or $0.51 per Share, an Increase of 8.3% Year-over-Year Q3 2024 NII Provides 128% Coverage of the Base Cash Distribution Q3 2024 Total Gross Debt and Equity Commitments of $430.7 Million Q3 2024 Total Gross Fundings of $272.0 Million Conservative Balance Sheet Management with Net GAAP Leverage of 92.5% and Net Regulatory Leverage of 83.0% Undistributed Earnings Spillover of $152.1 Million, or $0.94(1) per Ending Shares Outstanding Approximately $4.6 Billion of Assets Under Management, an Increase of 10.9% Year-over-Year(2) Hercules Capital

    $HCXY
    $HTGC
    Investment Managers
    Finance
  • Hercules Capital Announces Date for Release of Third Quarter 2024 Financial Results and Conference Call

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2024 financial results conference call for Wednesday, October 30, 2024, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access

    $HCXY
    $HTGC
    Investment Managers
    Finance
  • Hercules Capital Reports Second Quarter 2024 Financial Results

    Q2 2024 Total Gross Debt and Equity Commitments of $686.5 Million Record Q2 2024 Total Gross Fundings of $461.5 Million, an Increase of 28.7% Year-over-Year Record Q2 2024 Total Investment Income of $125.0 Million, an Increase of 7.5% Year-over-Year Q2 2024 Net Investment Income "NII" of $82.4 Million, or $0.51 per Share, an Increase of 8.8% Year-over-Year Q2 2024 NII Provides 128% Coverage of the Base Cash Distribution Conservative Balance Sheet Management with Net GAAP Leverage of 93.3% and Net Regulatory Leverage of 83.9% Undistributed Earnings Spillover of $145.0 Million, or $0.89(1) per Ending Shares Outstanding Approximately $4.6 Billion of Assets Under Management, an In

    $HCXY
    $HTGC
    Investment Managers
    Finance

$HCXY
$HTGC
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more